A new analysis reveals biotech companies dominated the top 10 funding rounds in the Netherlands during the first half of 2025. While Q1 saw a low of $503 million in total funding, the overall H1 figure reached $1.4 billion. This represents a decrease from the $1.8 billion raised during the same period last year. The 'Funding Focus' series by The Next Web examines cash flow within the European tech ecosystem, highlighting key investment trends and sectors driving growth in the Dutch market.